-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Amgen, Raises Price Target to $530

Benzinga·11/05/2026 00:07:18
UBS analyst Michael Yee maintains Amgen (NASDAQ:AMGN) with a Buy and raises the price target from $470 to $530.